These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3332167)

  • 1. Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation.
    Johnson NT; Crawford SW; Sargur M
    Bone Marrow Transplant; 1987 Aug; 2(2):203-7. PubMed ID: 3332167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Openshaw H; Slatkin NE; Stein AS; Hinton DR; Forman SJ
    Cancer; 1996 Nov; 78(9):1899-905. PubMed ID: 8909309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation.
    Eliashiv S; Brenner T; Abramsky O; Shahin R; Agai E; Naparstek E; Steiner I
    Bone Marrow Transplant; 1991 Oct; 8(4):315-7. PubMed ID: 1756330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.
    Kornblau SM; Cortes-Franco J; Estey E
    Leukemia; 1993 Mar; 7(3):378-83. PubMed ID: 8445943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.
    Rodriguez V; Kuehnle I; Heslop HE; Khan S; Krance RA
    Bone Marrow Transplant; 2002 Mar; 29(6):515-7. PubMed ID: 11960272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
    Nevill TJ; Benstead TJ; McCormick CW; Hayne OA
    Am J Hematol; 1989 Dec; 32(4):314-5. PubMed ID: 2554727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
    Przepiorka D; Gonzales-Chambers R
    Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
    Saito T; Asai O; Dobashi N; Yano S; Osawa H; Takei Y; Takahara S; Ogasawara Y; Yamaguchi Y; Minami J; Usui N
    J Infect Chemother; 2006 Jun; 12(3):148-51. PubMed ID: 16826348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain Barré syndrome, a possible side effect of buffy coat transfusion and IFN alpha therapy in relapsed CML after bone marrow transplantation.
    Schwarzer A; Schulze E; Leiblein S; Krahl R; Kubel M; Bartram C; Edelmann J; Sack U; Helbig W
    Ann Oncol; 1995 Jul; 6(6):617. PubMed ID: 8573544
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-supralethal mitobronitol/cytarabine/cyclophosphamide conditioning without irradiation before bone marrow transplantation for accelerated chronic granulocytic leukemia: apparent absence of acute graft-versus-host disease.
    Kelemen E; Jakab K; Váradi G; Jánossa M; Földi J; Dénes R
    Leukemia; 1993 Jul; 7(7):939-45. PubMed ID: 8321045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
    Grant S; Baker M; Bhalla K
    Leukemia; 1993 Dec; 7(12):1933-8. PubMed ID: 8255091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy after bone marrow transplantation.
    Openshaw H
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):202-9. PubMed ID: 9360782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual case of leukoencephalopathy after bone marrow transplantation.
    Li CK; Kwan WH; Shing MM; Yuen PM
    Pediatr Hematol Oncol; 1994; 11(6):651-6. PubMed ID: 7857788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
    Amadori S; Picardi A; Fazi P; Testi AM; Petti MC; Montefusco E; Mandelli F
    Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
    Vogler WR; Winton EF; Heffner LT; Gordon DS; Sternberg P; Crocker I; Reynolds R; Dobbs CK
    Bone Marrow Transplant; 1990 Dec; 6(6):405-9. PubMed ID: 2097009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.